Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
8.19M
-
Shares change
-
+3.72M
-
Total reported value, excl. options
-
$21M
-
Value change
-
+$9.62M
-
Put/Call ratio
-
0.24
-
Number of buys
-
42
-
Number of sells
-
-15
-
Price
-
$2.56
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q1 2025
74 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q1 2025.
Protalix BioTherapeutics, Inc. - COM (PLX) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.19M shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (1.19M shares), MILLENNIUM MANAGEMENT LLC (963K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (859K shares), NORTHERN TRUST CORP (685K shares), MARSHALL WACE, LLP (615K shares), Connor, Clark & Lunn Investment Management Ltd. (483K shares), Stratos Wealth Partners, LTD. (346K shares), JANE STREET GROUP, LLC (294K shares), GOLDMAN SACHS GROUP INC (289K shares), and BlackRock, Inc. (255K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.